Metagenomic Sequencing Market Overview
Metagenomics sequencing, also known as environmental or community genomics is an approach that allows insight to be gained into community biodiversity and function. In the process of metagenomics sequencing, the DNA of the specified host microorganism is extracted and cloned directly from the microorganism using genetic analyses of DNA. The function of metagenomic sequencing market which is to sequence the genomes of untargeted cells in a community in order to elucidate community composition and function helps to understand the several types of cells in a community and what organisms are present in their physiology.
Research using the metagenomic sequencing taps into several fields due to the broad existence of large microbial communities. For instance; the study of soil microbiota has led to advances in understanding and treating plant pathogens. Whereas. In human gut microbiota, the use of metagenomics discovered how common antibiotic genes are in the gut bacteria.
Moreover, increasing RD activities to identify new antibiotics and enzymes, and improved bioinformatics support market growth, offering some attractive opportunities to the key market players.Conversely, factors such as the rising concerns related to the standardization and accuracy of diagnostic testing alongside the lack of skilled professionals and knowledge are expected to impede the market growth over the forecast period. Nevertheless, public and private funding programs that are rapidly increasing are expected to support the market growth providing sufficient funds for RD 16s metagenomic sequencing.
Global Metagenomic sequencing Market Segment
MRFR has segmented the report into four key dynamics for an easy grasp;
By Technology: Sequencing and Bioinformatics among others.
By Application : Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, and Agriculture among others.
By End-user : Hospitals, Research Institutes, and Specialized Clinics among others.
By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World (RoW).
Metagenomic sequencing Market Regional Analysis
The North American region leads the global metagenomic sequencing market owing to the presence of global players who are focused on introducing the procedures with innovative technology. Encouraging governmental support for RD activities in healthcare and metagenomic sequencing tests is acting as a significant tailwind that is pushing up the market.
Additional factors encouraging the growth of the market include increased uptake of advanced technologies in the next generation sequencing procedures and its increasing applications and high healthcare expenditures.
The metagenomic sequencing market in the US backed the increasing demand for metagenomic sequencing, contributes to the growth of the regional market majorly. Heading with the rising demands for metagenomic sequencing procedures, the region will create a larger revenue pocket in the global metagenomic sequencing market by 2023.
Heading with the significant advancements of technologies and their wide uptake in the medical sector, the metagenomic sequencing market in the European region holds the second position in terms of size.
Moreover, the presence of a flourishing medical devices market and rising healthcare expenditure in the region will facilitate the growth of the market. Also, factors such as support and funding from public private sectors for research development impacts the market growth in the region positively.
Metagenomic sequencing Market Key Players:
Players leading the global metagenomic sequencing market include Enterome Bioscience (France), GATC Biotech AG (Germany), Aperiomics, Inc. (U.S.), Illumina Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), Second Genome Therapeutics (U.S.), SciGenom Labs Pvt. Ltd. (India), Quest Diagnostics Incorporated (U.S.), GenapSys, Inc. (U.S.), Freenome Inc. (U.S.), COSMOSID (U.S.), Beijing Genomics Institute (China), Pacific Biosciences (U.S.), Biomatters Ltd. (New Zealand), Oxford Nanopore Technologies Inc. (UK), Thermo Fisher Scientific Inc. (U.S.), CLC Bio (Qiagen) (Denmark), DNAStar Inc. (U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Knome Inc. (U.S.), and Helicos BioSciences (U.S.) among others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
